Friday, 18 Oct 2019

You are here

Limited Counseling for Increased Sodium Intake in the U.S.

Increased sodium intake has been shown to increase Th17 cell activity, and in animal models high-salt diets have been shown to drive IL-23-dependent TH17 cells to cause experimental allergic encephalomyelitis (citation source (http://url.ie/z238). In humans, high-salt diets have been shown to increase clinical and imaging activity in multiple sclerosis (citation source http://url.ie/z239). The consequences of dietary salt on other autoimmune disease is not known.

Dietary salt has been linked to hypertension, heart disease and stroke. The CDC has studied salt intake and from 2011–2012, the average daily sodium intake among U.S. adults was estimated to be 3,592 mg, well above above the Healthy People 2020 target of 2,300 mg daily. A 2013 Behavioral Risk Factor Surveillance System (BRFSS) survey sought to assess nationwide strategies to reduce salt intake. They reported that among the survey respondents, the median prevalence of taking action to reduce sodium intake was 51%, ranging from 39% to 73%. However, prevalence of receiving health professional advice to reduce sodium intake was lower at 22%, ranging from 14% to 41%.  

Despite the evident and potential benefits of limiting salt, most physicians fail to counsel their patients on the advantages of salt restriction.

Add new comment

More Like This

Protective Effects of ASA and Vasodilators in Systemic Sclerosis

A large cohort study suggests that the use of vasodilators and aspirin (ASA) in systemic sclerosis (SSc) may yield favorable  cardiovascular outcomes.

Myositis Patients at High Risk of Opportunistic Infections

Among patients with systemic rheumatic diseases, the highest incidence of opportunistic infections was seen in those with polymyositis/dermatomyositis (PM/DM), Taiwanese researchers found.

Warfarin Superior to Xarelto in Antiphospholipid Syndrome

A 3 year, multicenter, European, study shows that rivaroxaban was inferior to warfarin in preventing thrombosis in patients with antiphospholipid syndrome (APS) according to the Annals of Internal Medicine. Thus despite the inconvenience of warfarin, it remains the best option for patients with APS.

Declining Trends in Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis Mortality in the USA

Annals of Internal Medicine reports that age-adjusted mortality rates for antineutrophil cytoplasmic autoantibody–associated vasculitides (AAV) have improved over time - with a decline of nearly 2 percent per year in the United States from 1999 to 2017. Nevertheless, long-term outcomes continue to lag behind mortality rates of the general population.

Serum Interferon Predicts Lupus Flares

Elevated serum levels of interferon-α among patients whose systemic lupus erythematosus (SLE) was in remission helped predict future disease flares, European researchers found.

Among 254 SLE patients who were in remission, 26% had abnormally high serum levels of interferon-α at baseline, according to Alexis Mathian, MD, of Pitié-Salpêtrière Hospital in Paris, and colleagues.